Mexitil and Meropenem drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mexitil (mexiletine hydrochloride) and Meropenem (meropenem). Common drug interactions include epistaxis among females and renal failure among males.
The phase IV clinical study analyzes what interactions people have when they take Mexitil and Meropenem. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Mexitil?
Mexitil has active ingredients of mexiletine hydrochloride. eHealthMe is studying from 1,893 Mexitil users. Check the latest studies of Mexitil.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
12 people who take Mexitil and Meropenem together, and have interactions are studied.

What are the common drug interactions of Mexitil and Meropenem, by gender? *:
female:
- Epistaxis (bleed from the nose)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Thrombocytopenia (decrease of platelets in blood)
- White blood cell count decreased
- International normalised ratio increased
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Abdominal pain
- Infection
- Pain in extremity
male:
- Renal failure (kidney dysfunction)
- Blood creatinine increased
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
- Renal impairment (severely reduced kidney function)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Vomiting
- Arrhythmia (irregular heartbeat)
- Blood lactate dehydrogenase increased
- Blood uric acid increased
What are the common drug interactions of Mexitil and Meropenem, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- C-reactive protein increased
- Fungaemia (fungi circulate in the blood)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Sepsis (a severe blood infection that can lead to organ failure and death)
60+:
- Renal failure (kidney dysfunction)
- Blood creatinine increased
- Hyperkalaemia (damage to or disease of the kidney)
- Hypertension (high blood pressure)
- Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
- Infection
- International normalised ratio increased
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
- Renal impairment (severely reduced kidney function)
What are the existing conditions these people have? *
- High Blood Pressure: 8 people, 66.67%
- Arrhythmias (irregular heartbeat): 4 people, 33.33%
- Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 25.00%
- Constipation: 3 people, 25.00%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 25.00%
- Gastritis (inflammation of stomach): 2 people, 16.67%
- Cancer Pain: 2 people, 16.67%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 16.67%
- Insomnia (sleeplessness): 2 people, 16.67%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Mexitil and Meropenem?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Mexitil and Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mexitil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mexitil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mexiletine hydrochloride and meropenem (the active ingredients of Mexitil and Meropenem, respectively), and Mexitil and Meropenem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Loratadine cause Family Stress? - 3 seconds ago
- Could Femara cause Neoplasm Progression? - 28 seconds ago
- Lantus and Asmanex Twisthaler drug interactions for men aged 60+ - 29 seconds ago
- Could Naloxone cause Headache? - 49 seconds ago
- Could Extavia cause Injection Site Urticaria? - a minute ago
- Could Exjade cause Pigmentation Disorder? - a minute ago
- Could Evista cause Aggression? - a minute ago
- Could Estradiol cause Cardio-Respiratory Arrest? - a minute ago
- Could Norvasc cause Oedema Mouth? - a minute ago
- Trimethoprim and Anaemia for Women aged 60+ - a minute ago